Tens of thousands of Americans with tumors from certain types of lung cancer have mutations that might be treated by new drugs that are already in the pipeline or that could be easily developed–a dramatic demonstration of the promise of personalized genomic-based medicine.
Additional Resources:
- Scientists delve into lung cancer genome, Milwaukee Journal Sentinel
View the original article here: Personal genomics: New drugs target common cancers